Tech Nuggets with the Technology: Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments (Lizette Chapman/Bloomberg)

Monday, December 7, 2020

Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments (Lizette Chapman/Bloomberg)

Lizette Chapman / Bloomberg:
Palantir wins a three-year deal worth $44.4M with the FDA to use Palantir software to power drug reviews and inspections, including possible COVID-19 treatments — Palantir Technologies Inc. won a deal with the U.S. Food and Drug Administration to help power drug reviews and inspections …

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)